HDAC inhibitor CHDI-390576, Purity ≥98%

Cat. No.: X23-10-ZQ269

HDAC inhibitor CHDI-390576, Purity ≥98%

Synonym: 936221-33-9; 2-(2-Fluorophenyl)-N-hydroxy-2-[4-[5-(trifluoromethyl)pyrimidin-2-yl]phenyl]acetamide; 2-(2-Fluorophenyl)-N-hydroxy-2-(4-(5-(trifluoromethyl)pyrimidin-2-yl)phenyl)acetamide; HDAC inhibitor

  • CAS Number: 1629729-98-1
  • Compound CID: 81689842
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
CHDI-390576 induces DNA damage and the inhibition of DNA repair processes. It targets HDAC1, HDAC3, HDAC4, HDAC5, HDAC7, HDAC8, hHDAC6, and hHDAC9.
Molecular Weight
391.33
Molecular Formula
C19H13F4N3O2
Targets
HDAC1: 39.7 μM; HDAC3: 25.8 μM; HDAC4: 54 nM; HDAC5: 60 nM; HDAC7: 31 nM; HDAC8: 9.1 μM; hHDAC6: 6.2 μM; hHDAC9: 50 μM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
CHDI-390576 is employed to investigate its efficacy as an HDAC inhibitor in pre-clinical models of neurodegenerative diseases such as Huntington's disease.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.